2010-19年非洲25个国家季节性流感流行的时机:一项回顾性分析
该研究利用2010-19年向WHO FluNet平台报告的非洲国家哨点监测数据,计算3周移动流感病毒阳性样本比例,采用聚合平均法评估流行时机。在34个报告数据的国家中,25个有至少3年数据,共报告503609份呼吸道病毒RT-PCR检测结果,其中74001份(15%)流感病毒阳性;共识别248次流行,涉及236个国家年数据。多数国家有可识别的流感流行期,可用于指导疫苗时机和及时干预。
要点
- 25个非洲国家共报告503609份呼吸道样本RT-PCR结果,流感阳性74001份(15%)。
- 识别出248次流行,涉及236个国家年数据,每国中位10次(范围7-10)。
- 6国(24%)为北半球模式,8国(32%)主要为北半球模式,3国(12%)主要为南半球模式,3国(12%)为南半球模式,5国(20%)无清晰模式。
核心结论
- 多数国家有可识别的流感流行期,可用于告知当局非季节性和季节性流感活动、指导疫苗时机并促进及时干预。
研究设计与样本
- 回顾性分析,使用2010-19年向WHO全球流感监测和应对系统FluNet平台报告的非洲国家公开哨点数据,纳入有3-10年数据的国家。
主要发现
- 34个向FluNet报告数据的国家中,25个有至少3年数据,占非洲国家的46%和非洲人口的89%。
- 研究国家共报告503609份RT-PCR呼吸道病毒检测结果(每国家年中位数12971,IQR 9607-20960),其中74001份(15%;每国家年中位数2078,IQR 1087-3008)流感病毒阳性。
- 共发生248次流行,涉及236个国家年数据(每国中位数10次,范围7-10)。
- 6国(24%)为北半球模式(阿尔及利亚、布基纳法索、埃及、摩洛哥、尼日尔和突尼斯)。
- 8国(32%)为主要为北半球模式伴部分南半球流行(喀麦隆、埃塞俄比亚、马里、莫桑比克、尼日利亚、塞内加尔、坦桑尼亚和多哥);3国(12%)为主要为南半球模式伴部分北半球流行(加纳、肯尼亚和乌干达);3国(12%)为南半球模式(中非共和国、南非和赞比亚);5国(20%)无清晰模式(科特迪瓦、刚果民主共和国、马达加斯加、毛里求斯和卢旺达)。
临床怎么用
- 原文指出多数国家有可识别的流感流行期,可用于告知当局非季节性和季节性流感活动、指导疫苗时机并促进及时干预。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Using country-specific surveillance data to describe influenza epidemic activity could inform decisions on the timing of influenza vaccination. We analysed surveillance data from African countries to characterise the timing of seasonal influenza epidemics to inform national vaccination strategies. METHODS: We used publicly available sentinel data from African countries reporting to the WHO Global Influenza Surveillance and Response FluNet platform that had 3-10 years of data collected during 2010-19. We calculated a 3-week moving proportion of samples positive for influenza virus and assessed epidemic timing using an aggregate average method. The start and end of each epidemic were defined as the first week when the proportion of positive samples exceeded or went below the annual mean, respectively, for at least 3 consecutive weeks. We categorised countries into five epidemic patterns: northern hemisphere-dominant, with epidemics occurring in October-March; southern hemisphere-dominant, with epidemics occurring in April-September; primarily northern hemisphere with some epidemic activity in southern hemisphere months; primarily southern hemisphere with some epidemic activity in northern hemisphere months; and year-round influenza transmission without a discernible northern hemisphere or southern hemisphere predominance (no clear pattern). FINDINGS: Of the 34 countries reporting data to FluNet, 25 had at least 3 years of data, representing 46% of the countries in Africa and 89% of Africa's population. Study countries reported RT-PCR respiratory virus results for a total of 503 609 specimens (median 12 971 [IQR 9607-20 960] per country-year), of which 74 001 (15%; median 2078 [IQR 1087-3008] per country-year) were positive for influenza viruses. 248 epidemics occurred across 236 country-years of data (median 10 [range 7-10] per country). Six (24%) countries had a northern hemisphere pattern (Algeria, Burkina Faso, Egypt, Morocco, Niger, and Tunisia). Eight (32%) had a primarily northern hemisphere pattern with some southern hemisphere epidemics (Cameroon, Ethiopia, Mali, Mozambique, Nigeria, Senegal, Tanzania, and Togo). Three (12%) had a primarily southern hemisphere pattern with some northern hemisphere epidemics (Ghana, Kenya, and Uganda). Three (12%) had a southern hemisphere pattern (Central African Republic, South Africa, and Zambia). Five (20%) had no clear pattern (Côte d'Ivoire, DR Congo, Madagascar, Mauritius, and Rwanda). INTERPRETATION: Most countries had identifiable influenza epidemic periods that could be used to inform authorities of non-seasonal and seasonal influenza activity, guide vaccine timing, and promote timely interventions. FUNDING: None. TRANSLATIONS: For the Berber, Luganda, Xhosa, Chewa, Yoruba, Igbo, Hausa and Afan Oromo translations of the abstract see Supplementary Materials section.
引用
- Igboh LS, Roguski K, Marcenac P, et al. Timing of seasonal influenza epidemics for 25 countries in Africa during 2010-19: a retrospective analysis. Lancet Glob Health. 2023. PMID: 37061311. doi:10.1016/S2214-109X(23)00109-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。